These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28899969)

  • 1. TMEM16A/ANO1 Inhibits Apoptosis Via Downregulation of Bim Expression.
    Godse NR; Khan N; Yochum ZA; Gomez-Casal R; Kemp C; Shiwarski DJ; Seethala RS; Kulich S; Seshadri M; Burns TF; Duvvuri U
    Clin Cancer Res; 2017 Dec; 23(23):7324-7332. PubMed ID: 28899969
    [No Abstract]   [Full Text] [Related]  

  • 2. TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation.
    Dixit R; Kemp C; Kulich S; Seethala R; Chiosea S; Ling S; Ha PK; Duvvuri U
    Sci Rep; 2015 Nov; 5():16657. PubMed ID: 26563938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer.
    Stauber RH; Knauer SK; Habtemichael N; Bier C; Unruhe B; Weisheit S; Spange S; Nonnenmacher F; Fetz V; Ginter T; Reichardt S; Liebmann C; Schneider G; Krämer OH
    Oncotarget; 2012 Jan; 3(1):31-43. PubMed ID: 22289787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin inhibits oral squamous cell carcinoma by targeting TMEM16A Ca
    Wang H; Wang T; Zhang Z; Fan Y; Zhang L; Gao K; Luo S; Xiao Q; Sun C
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1699-1711. PubMed ID: 33755783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMEM16A inhibits autophagy and promotes the invasion of hypopharyngeal squamous cell carcinoma through mTOR pathway.
    Yang X; Cui L; Liu Z; Li Y; Wu X; Tian R; Jia C; Ren C; Mou Y; Song X
    Carcinogenesis; 2024 Aug; 45(8):569-581. PubMed ID: 38470063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2.
    Kulkarni S; Bill A; Godse NR; Khan NI; Kass JI; Steehler K; Kemp C; Davis K; Bertrand CA; Vyas AR; Holt DE; Grandis JR; Gaither LA; Duvvuri U
    Genes Chromosomes Cancer; 2017 Jun; 56(6):460-471. PubMed ID: 28177558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To "grow" or "go": TMEM16A expression as a switch between tumor growth and metastasis in SCCHN.
    Shiwarski DJ; Shao C; Bill A; Kim J; Xiao D; Bertrand CA; Seethala RS; Sano D; Myers JN; Ha P; Grandis J; Gaither LA; Puthenveedu MA; Duvvuri U
    Clin Cancer Res; 2014 Sep; 20(17):4673-88. PubMed ID: 24919570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.
    Bae WJ; Koo BS; Lee SH; Kim JM; Rho YS; Lim JY; Moon JH; Cho JH; Lim YC
    Br J Cancer; 2017 Dec; 117(12):1810-1818. PubMed ID: 29096401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Ca
    Liu Z; Zhang S; Hou F; Zhang C; Gao J; Wang K
    Int J Cancer; 2019 May; 144(9):2215-2226. PubMed ID: 30243029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper-dependent ATP7B up-regulation drives the resistance of TMEM16A-overexpressing head-and-neck cancer models to platinum toxicity.
    Vyas A; Duvvuri U; Kiselyov K
    Biochem J; 2019 Dec; 476(24):3705-3719. PubMed ID: 31790150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells.
    Basak SK; Zinabadi A; Wu AW; Venkatesan N; Duarte VM; Kang JJ; Dalgard CL; Srivastava M; Sarkar FH; Wang MB; Srivatsan ES
    Oncotarget; 2015 Jul; 6(21):18504-17. PubMed ID: 26098778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy.
    Vyas A; Gomez-Casal R; Cruz-Rangel S; Villanueva H; Sikora AG; Rajagopalan P; Basu D; Pacheco J; Hammond GRV; Kiselyov K; Duvvuri U
    Proc Natl Acad Sci U S A; 2022 Mar; 119(12):e2100670119. PubMed ID: 35286200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
    Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
    Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.
    Lee TK; Poon RT; Wo JY; Ma S; Guan XY; Myers JN; Altevogt P; Yuen AP
    Cancer Res; 2007 Sep; 67(18):8800-9. PubMed ID: 17875721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer.
    Yassin-Kassab A; Chatterjee S; Khan N; Wang N; Sandulache VC; Huang EH; Burns TF; Duvvuri U
    BMC Cancer; 2024 Feb; 24(1):233. PubMed ID: 38373988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas.
    Rodrigo JP; Menéndez ST; Hermida-Prado F; Álvarez-Teijeiro S; Villaronga MÁ; Alonso-Durán L; Vallina A; Martínez-Camblor P; Astudillo A; Suárez C; María García-Pedrero J
    Sci Rep; 2015 Oct; 5():15698. PubMed ID: 26498851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers.
    Li F; Shanmugam MK; Siveen KS; Wang F; Ong TH; Loo SY; Swamy MM; Mandal S; Kumar AP; Goh BC; Kundu T; Ahn KS; Wang LZ; Hui KM; Sethi G
    Oncotarget; 2015 Mar; 6(7):5147-63. PubMed ID: 25762616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volume-regulated chloride channel regulates cell proliferation and is involved in the possible interaction between TMEM16A and LRRC8A in human metastatic oral squamous cell carcinoma cells.
    Yoshimoto S; Matsuda M; Kato K; Jimi E; Takeuchi H; Nakano S; Kajioka S; Matsuzaki E; Hirofuji T; Inoue R; Hirata M; Morita H
    Eur J Pharmacol; 2021 Mar; 895():173881. PubMed ID: 33476655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer.
    Bauer JA; Kumar B; Cordell KG; Prince ME; Tran HH; Wolf GT; Chepeha DB; Teknos TN; Wang S; Eisbruch A; Tsien CI; Urba SG; Worden FP; Lee J; Griffith KA; Taylor JM; D'Silva N; Wang SJ; Wolter KG; Henson B; Fisher SG; Carey TE; Bradford CR
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S106-8. PubMed ID: 17848273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis.
    Ruiz C; Martins JR; Rudin F; Schneider S; Dietsche T; Fischer CA; Tornillo L; Terracciano LM; Schreiber R; Bubendorf L; Kunzelmann K
    PLoS One; 2012; 7(8):e43265. PubMed ID: 22912841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.